Silo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset

Strategic decision positions Company to diversify treasury holdings with a long-term digital store of valueSARASOTA, FL, June 05, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced that its Board of Directors has approved the purchase of up to $1 million in Bitcoin as a treasury reserve asset. “The addition of Bitcoin to our treasury holdings is a strate ...